A functional human IgM response to HIV-1 Env after immunization with NYVAC HIV C

AIDS. 2007 Feb 19;21(4):524-7. doi: 10.1097/QAD.0b013e32803277f9.

Abstract

Env-specific IgG and IgM were detected in 25 and 60%, respectively, of volunteers immunized with NYVAC expressing clade C gp120. The serum sample with the highest IgM titre but undetectable IgG neutralized the homologous isolate with a reciprocal IC90 titre of 7.8 in the absence of complement, and 24.4 in the presence of complement (P = 0.0003). These results suggest that vaccine-induced, Env-specific IgM may have antiviral activity and should be subjected to further investigation.

Publication types

  • Controlled Clinical Trial
  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS Vaccines / immunology*
  • HIV Antibodies / biosynthesis*
  • HIV Envelope Protein gp120 / immunology
  • HIV-1 / immunology*
  • Humans
  • Immunoglobulin G / biosynthesis
  • Immunoglobulin M / biosynthesis*
  • Viral Vaccines / immunology*

Substances

  • AIDS Vaccines
  • HIV Antibodies
  • HIV Envelope Protein gp120
  • Immunoglobulin G
  • Immunoglobulin M
  • NYVAC vaccine
  • Viral Vaccines